PIN SIANG MEDICAL BIOTECHNOLOGY CO., LTD.

🇹🇼Taiwan
Ownership
-
Employees
-
Market Cap
-
Website

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.

Not Applicable
Conditions
Interventions
First Posted Date
2013-11-13
Last Posted Date
2013-11-13
Lead Sponsor
Pin Siang Medical Biotechnology Co., Ltd.
Target Recruit Count
40
Registration Number
NCT01982461
Locations
🇨🇳

Tri-Service General Hospital, Taipei, Taiwan

© Copyright 2024. All Rights Reserved by MedPath